Personalized Melanoma Vaccine Could Be a ‘Game Changer’ by Teaching the Body to Fight Cancer Cells. The mRNA therapy, designed to prevent treated skin cancer from returning, is entering its third phase of trials.
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
New Malaria Vaccine Proven Effective in Phase 3 Study
First Phase of Europe's Huge New Atom Smasher Could Be 20 Years Away
Revolutionary Sepsis Treatment Moves to Next Phase of Human Trials
Vectorial Adaptive Optics: A New Horizon in Phase and Polarization Correction
Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses
Titan Dragonfly is Go!…. for Phase C
Findings from a phase 1 trial show that a single dose of an experimental therapy produced greater than 94% reductions in blood levels of lipoprotein(a), a key driver of heart disease risk, with the results lasting for nearly a year
Medical discovery for sepsis moves to next phase of human trials
The Arecibo Observatory's next phase as a STEM education center starts in 2024
A New Dawn for Alzheimer’s: Phase I Trial Targets Senescent Cells Safely
Phase I Clinical Trial Shows Treatment Designed to Clear Senescent Cells in Alzheimer’s Disease is Safe
Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe
New material offers more durable, sustainable multi-level non-volatile phase change memory
/https%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2F76%2F88%2F7688aa34-7a9c-4dd6-8bb7-6eff53feb9b1%2F52609627579_a49df9da0a_o.jpg)
